Easter Closure Notice:
The NHS Wales Joint Commissioning Committee will be closed over the Easter period from Friday 3 April to Monday 6 April 2026.
Enquiries will be responded to from Tuesday 7 April 2026. Thank you for your patience.
Stereotactic ablative body radiotherapy (SABR) for patients aged 18 years old and above (PP278), Policy Position Statement, August 2023.pdf (PDF, 613Kb)
Stereotactic ablative body radiotherapy (SABR) for patients aged 18 years old and above with (LANPC) (PP280), Policy Position Statement, August 2023.pdf (PDF, 427Kb)
Stereotactic Ablative Body Radiotherapy (SABR) for patients with metachronous extracranial oligometastic cancer (all ages), Commissioning Policy (CP121), December 2024.pdf (PDF, 551Kb)
Stereotactic Ablative Body Radiotherapy (SABR) for the management of Non-Small Cell Lung Cancer in people aged 18 years and above, Commissioning Policy (CP76), June 2023.pdf (PDF, 327Kb)
Stereotactic Ablative Radiotherapy (SABR) for people aged 18 years old and above with primary kidney cancer, Commissioning Policy (CP279), June 2024.pdf (PDF, 512Kb)
Use of plerixafor for stem cell mobilisation for CTYA with lymphoma and paediatric type solid tumours, Policy Position Statement (PP154), July 2024.pdf (PDF, 208Kb)
Vonicog alfa for the treatment and prevention of bleeding in people of all ages with von Willebrand disease, Policy Position Statement (PP215), October 2023.pdf (PDF, 353Kb)